Best Practices for Diagnosing and Managing Graves' Disease
Author Information
Author(s): Kalra Sanjay, Selim Shahjada, Shrestha Dina, Somasundaram Noel, Raza Syed Abbas, Baruah Manash P., Bhattacharya Saptarshi, Gadve Sharvil, Bantwal Ganapathi, Sahay Rakesh
Hypothesis
The inclusion of TSH Receptor Antibodies (TRAbs) in the diagnostic algorithm for Graves' disease can improve management outcomes.
Conclusion
TRAbs play a crucial role in the diagnosis, management, and monitoring of Graves' disease, particularly in South Asia.
Supporting Evidence
- TRAbs measurement improves the time to diagnosis by 46%.
- TRAbs can help predict treatment response and prognosis in Graves' disease.
- High TRAbs levels are associated with a greater risk of disease relapse.
Takeaway
Graves' disease is a condition that affects the thyroid, and measuring specific antibodies can help doctors make better decisions about treatment.
Methodology
A panel of experienced endocrinologists reviewed literature and developed recommendations based on evidence.
Potential Biases
Potential bias due to reliance on expert opinion rather than extensive clinical trials.
Limitations
The recommendations are based on expert opinion and need validation from larger cohorts; TRAbs availability is limited in South Asia.
Participant Demographics
Endocrinologists with a minimum of 10 years of experience in thyroid disorders.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 1.02–1.08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website